ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

Obesity At Prostate-Cancer Diagnosis Increases Risk

March 30, 2007

Automated Thermography System Said to Be As Good As Mammography Developed for Mass Screening

July 4, 1980

DOD Seeks to Fund Innovative Research In 438 Million Prostate Cancer Program

August 22, 1997

NCAB Committee Agrees On Seven Characteristics For Comprehensive Centers, Asks For New Division

May 12, 1989

NCI to Study Vasectomy And Prostate Cancer: DCE Concepts OK’d

July 2, 1993